What SK biotek does

SK biotek operates as a contract development and manufacturing organization (CDMO) specializing in small molecule active pharmaceutical ingredient (API) production, operating as a subsidiary brand within the SK pharmteco platform. The company provides end-to-end services spanning API drug substance development, custom API manufacturing, analytical services, and regulatory support, serving global pharmaceutical companies (primary segment) and biotechnology companies (secondary segment) from clinical through commercial scale. Its manufacturing footprint exceeds 1,000 m3 of capacity distributed across three continents, enabling gram-to-multi-ton production with full cGMP compliance.

The company's technical differentiation rests on proprietary process technologies including continuous flow processing, simulated moving bed (SMB) chromatography, biocatalysis, particle engineering, custom catalyst design, and specialized handling of high-potency APIs (HPAPIs) including cytotoxic compounds and antibody-drug conjugate (ADC) payloads and linkers. Beyond small molecules, the platform extends into peptide synthesis and viral vector manufacturing (AAV, Adenovirus, Lentivirus) for gene therapy applications. A dedicated project management model assigns a single point of contact per program to manage scope, timelines, and deliverables.

SK biotek generates revenue through project-based B2B contracts with pharmaceutical and biotech clients, with pricing negotiated per project based on scale, complexity, and service requirements. The go-to-market is direct enterprise sales with no channel intermediaries, supported by technical content marketing, conference participation at major industry events (CPHI, TIDES, BOS, World ADC), and thought leadership through white papers and webinars. The entity is privately held within the SK Group ecosystem, with legal operations in the United States (SK pharmteco Inc.), South Korea (SK Biotek Korea), and Ireland (SK Biotek Ireland).

Name

SK biotek

Legal name

SK pharmteco Inc.

Website

https://skbiotek.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

251–500 employees

Short description

SK biotek is a CDMO providing small molecule API development and manufacturing services, plus peptide and viral vector capabilities, to global pharmaceutical and biotech companies across clinical to commercial stages, operating within the SK pharmteco platform.

Ownership category

akta.pro rank

Headquarters

HQ city

Rancho Cordova

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Revenue model

1. Contract Development and Manufacturing Services: CDMO services providing drug substance development and manufacturing for pharmaceutical and biotech companies across clinical to commercial phases. Revenue generated through project-based contracts with pharmaceutical clients for API manufacturing, process development, and regulatory support services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

SK biotek is a Contract Development and Manufacturing Organization (CDMO) that produces Active Pharmaceutical Ingredients (APIs) for pharmaceutical and biotech companies. Its core business centers on small molecule manufacturing, with additional capabilities in peptides and viral vectors, delivered under cGMP standards to support global drug development and commercial supply.

Product overview

SK biotek operates as part of SK pharmteco, a Contract Development and Manufacturing Organization (CDMO) providing integrated pharmaceutical manufacturing services. The portfolio includes Small Molecule CDMO Services (API drug substance development, custom API manufacturing, analytical services, and regulatory support), Small Molecule Specialties (high potency APIs, chromatography, continuous flow processing, biocatalysis, and particle engineering), Peptide Synthesis, and Viral Vectors services (including AAV, Adenovirus, and Lentivirus manufacturing for gene therapies). The company offers end-to-end capabilities from clinical to commercial scale manufacturing with cGMP compliance.

Differentiator

Problem solved

Functional benefit

Products and services

• Small Molecule API Manufacturing

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Market position

Strengths1 record

Competitive moat5 records

Key risks1 record

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@SK_pharmteco
• LinkedInlinkedin.com/company/sk-biotek-ireland-limited
• Xx.com/skbiotek

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SK biotek